GovWire

In the table below we provide you with information about applications we have received to amend the specification of a patent under sections 27 and 75 before the court and the Office. The table also includes information about when you need to file an opposition if you wish to oppose the application to amend.

Where amendments have been filed electronically, you can obtain full details by selecting the patent number. If you are the patent owner(s), you should check these details carefully and inform us if there are any problems. Where amendments have been filed in paper form only, the symbol * appears in the table after the patent number.

In the case of amendments filed under section 75 before the court and under section 27 at the Office, reasons for the amendments are also provided.

You can obtain reasons for the amendments and full details of any amendments filed in paper form by contacting Litigation Section (telephone: +44 (0)1633 814334).

Opposition procedures

Section 75 before the court

If you want to oppose an amendment filed under section 75 before the court, you need to file a notice of opposition at the court. In the notice you need to set out clearly your reasons for opposing the amendment. You need to send us a copy of the notice and send a copy to anyone involved in the court proceedings. You need to do this within 14 days of the advertisement on our web site of the application to amend.

Section 75 before the comptroller and section 27 amendments

If you want to oppose an amendment filed under section 75 before the comptroller or an amendment filed under section 27, you need to complete and send us:

• 2 copies of form 15 with the fee of 50. You will need to pay a further fee of 350 later
• 2 copies of a statement setting out fully the facts of your case and what you want us to do

Opposition table 2022

Section	Patents Journal	Deadline for filing opposition	Patent number and title	International Classification	Proprietor, including court action number (if any) and address for service
27	6946 6 July 2022	4 weeks	GB2589494 (PDF, 279 KB, 5 pages) Capacitive power transmission cable	H01b	Enertechnics Holdings Limited
75 Before the Court	6945 29 June 2022	14 days	EP3023061 (PDF, 35.9 KB, 5 pages) Endoscopic device for causing hemostasis	A61B	Boston Scientific Limited HP-2022-000007 Simmons & Simmons LLP Citypoint 1 Ropemaker Street London EC2Y 9SS
75 Before the Court	6945 29 June 2022	14 days	EP3716560 (PDF, 145 KB, 2 pages) Processing transmission signals in radio transmitter	H04L	Nokia Technologies OY HP-2021-000023 Bird & Bird LLP 12 New Fetter Lane London EC4A 1JP
75 Before the Court	6945 29 June 2022	14 days	EP2657519 (PDF, 104 KB, 1 page) Wind turbine	F03D	Siemens Gamesa Renewable Energy A/S HP-2021-000011 Bristows LLP 100 Victoria Embankment London EC4Y 0DH
75 Before the Court	6944 22 June 2022	14 days	EP1879471 (PDF, 210 KB, 2 pages) Flavouring composition concentrates	A23L	Soluble Technologies Group LLP IP-2021-000102 Shakespeare Martineau LLP Waterfront House Waterfront Plaza 35 Station Street Nottingham NG2 3DQ
75 Before the Court	6944 22 June 2022	14 days	EP2962962 (PDF, 164 KB, 1 page) Robot for transporting storage bins	B65G	Autostore Technology AS HP-2020-000035 Kirkland & Ellis International LLP 30 St Mary Axe London EC3A 8AF
75 Before the Court	6939 18 May 2022	14 days	GB2447295 (PDF, 247 KB, 4 pages) Sealing device	E04B	Manthorpe Building Products Limited HP-2022-000004 Marks & Clerk Law LLP 15 Fetter Lane London EC4A 1BW
27	6939 18 May 2022	4 weeks	GB2496107 (PDF, 77.5 KB, 3 pages) A method and apparatus for preventing unwanted code execution	G06F	Datawing Limited
27	6938 11 May 2022	4 weeks	GB2566809 (PDF, 2.57 MB, 6 pages) Heat transfer compositions	C09K	Mexichem Fluor S.A. de C.V.
75 Before the Court	6936 27 April 2022	14 days	EP2676967 Methods of treating inflammatory and autoimmune diseases with natalizumab	C07K	Biogen MA Inc. HP-2021-000031 Powell Gilbert LLP 85 Fleet Street London EC4Y 1AE
75 Before the Court	6934 13 April 2022	14 days	EP3017811 Apixaban formulations	A61K	Bristol-Myers Squibb Holdings Ireland Unlimited Company & Pfizer Inc. HP-2020-000048 HP-2021-000009 Hogan Lovells International LLP Atlantic House Holborn Viaduct London EC1A 2FG
75 Before the Court	6934 13 April 2022	14 days	EP3251660 Apixaban formulations	A61K	Bristol-Myers Squibb Holdings Ireland Unlimited Company & Pfi  View the original news story Related Articles Scroll Back To Top 📄More Articles Guidance: Requests to amend a patent after grantWednesday, 24 Aug Guidance: Requests to amend a patent after grantWednesday, 31 Aug Guidance: Requests to amend a patent after grantWednesday, 7 Sep Guidance: Requests to amend a patent after grantWednesday, 7 Sep Guidance: Requests to amend a patent after grantTuesday, 13 Sep Comments Scroll Back To Top ✎Write Comment We don't have any comments for this article yet. Why not join in and start a discussion. Write a Comment Scroll Back To Top Your name: Your email: Comments: Post my comment  Sponsored Advert   Ministerial Departmental News   PM's Office, 10 Downing Street   Cabinet Office   Department for Business, Innovation and Skills   Department for Communities and Local Government   Department for Culture, Media and Sport   Department for Education   Department for Environment, Food and Rural Affairs   Department for International Development   Department for Transport   Department for Work and Pensions   Department of Energy and Climate Change   Department of Health   Foreign and Commonwealth Office   HM Treasury   Home Office   Ministry of Defence   Ministry of Justice   Northern Ireland Office   Scotland Office   Wales Office   See all departments News Calendar Recent Comments  Sponsored Advert   Follow Us on Twitter Tweets by @gov_wire  Latest Government News Guidance: River Thames: current river conditions Guidance: River Thames: restrictions and closures Bluetongue virus – Latest situation: End of the seasonal low vector period Update on AUKUS export reform progress Bluetongue virus – Latest situation: End of the seasonal low vector period Guidance: Bluetongue: how to spot and report it Guidance: Apply for funding: space-related R&D, innovation and education Guidance: Closed opportunities: space-related R&D, innovation and education Enforcement appeals: Key changes under the Levelling Up and Regeneration Act Guidance: Feltham Prison and Young Offender Institution    Business Climate Crime Defence Economy Environment Housing Immigration NHS Overseas Schools Tax Transport Work ALL ❯ © 2024 Copyright CliqTo Media Ltd. Registered in England, company number 7575287. Privacy Policy | Terms & Conditions | Copyright Notice Contains public sector information licensed under the Open Government Licence v3.0. Share This Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: